Lately , there's increasing focus on the pharmaceutical sector in India . While multinational giants previously held significant sway , a change appears to be occurring. Several Indian entities have seen considerable growth , challenging the incumbent structure . Concerns are now being posed about whether this signifies a genuine transition toward

A recent analysis/investigation/study has shed light on the alarming rise/growth/escalation of monopoly power within India's pharmaceutical industry. This situation/trend/phenomenon is directly/severely/significantly impacting consumers/patients/citizens, forcing them to bear/shoulder/carry the burdens/cost/expenses of exorbitantly priced drugs. S